DIA Europe 2025スイス、バーゼルのブースF2でサターラをご訪問ください | March 18-20, 2025
サターラはライフサイエンス業界のイノベーターと連携することで、患者さんに医療を迅速に届けます。Together we advance modern drug development with biosimulation, regulatory science, and market access solutions. We use software, technology, and services to transform traditional drug discovery and development. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries.
CoAuthor
Regulatory writing technology needs to be smarter, user-friendly, and collaborative—and CoAuthor delivers. It streamlines the process with fast template selection, structured content authoring, and generative AI within Microsoft Word.
Leverage a biomedically-specialized GPT behind your firewall, for secure, prompt-based text generation
GlobalSubmit eCTD Platform
GlobalSubmit enables teams to manage the regulatory process so they can successfully publish, validate, and review eCTD submissions across a global footprint of regulatory health authorities.
Create submissions that conform to any or all of 9 health authorities’ required structure, XML, and validation report.
Review eCTD submissions across stakeholders prior to submitting
デモのご相談
コンテンツ
From molecule to market, Certara is your trusted partner in the drug development journey. Backed by a team of experts and innovative technology, we’re here to guide and support you at every stage. Explore our expertly curated resources, and feel free to reach out with any questions.
